GenoFocus Inc
KOSDAQ:187420
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
GenoFocus Inc
Cash & Cash Equivalents
GenoFocus Inc
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
GenoFocus Inc
KOSDAQ:187420
|
Cash & Cash Equivalents
₩33.5B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
14%
|
|
|
SK IE Technology Co Ltd
KRX:361610
|
Cash & Cash Equivalents
₩409B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Hansol Chemical Co Ltd
KRX:014680
|
Cash & Cash Equivalents
₩112.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
29%
|
|
|
D
|
Dongjin Semichem Co Ltd
KOSDAQ:005290
|
Cash & Cash Equivalents
₩371.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
21%
|
|
|
S
|
SoulBrain Co Ltd
KOSDAQ:357780
|
Cash & Cash Equivalents
₩241.6B
|
CAGR 3-Years
13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
I
|
Isu Specialty Chemical Co Ltd
KRX:457190
|
Cash & Cash Equivalents
₩30B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
GenoFocus Inc
Glance View
GenoFocus, Inc. engages the research and development of technologies related to biochemical and biotechnology industry. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2015-05-29. The firm mainly manufactures catalases, lactase, phytases and other enzymes. The catalases are mainly used for industry, including processing of semiconductors, petroleum and propylene oxide, medical therapeutics, food processing, contact-lens and other industries. The lactases are mainly used for food processing including processing of milk, yogurt and milk serum. The phytases are mainly used for processing of animal feed. And the Company is exploring new businesses, engaged in development of other enzymes including therapeutic enzymes, chemical agents and others.
See Also
What is GenoFocus Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
33.5B
KRW
Based on the financial report for Dec 31, 2025, GenoFocus Inc's Cash & Cash Equivalents amounts to 33.5B KRW.
What is GenoFocus Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
14%
Over the last year, the Cash & Cash Equivalents growth was -60%. The average annual Cash & Cash Equivalents growth rates for GenoFocus Inc have been -6% over the past three years , 9% over the past five years , and 14% over the past ten years .
